PASSAMONTI, FRANCESCO

PASSAMONTI, FRANCESCO  

DIPARTIMENTO DI MEDICINA E CHIRURGIA  

Mostra records
Risultati 1 - 20 di 264 (tempo di esecuzione: 0.033 secondi).
Titolo Data di pubblicazione Autore(i) File
Acquired copy-neutral loss of heterozygosity of chromosome 1p as a molecular event associated with marrow fibrosis in MPL-mutated myeloproliferative neoplasms 1-gen-2013 Rumi, E.; Pietra, D.; Guglielmelli, P.; Bordoni, R.; Casetti, I.; Milanesi, C.; Sant’Antonio, E.; Ferretti, V.; Pancrazzi, A.; Rotunno, G.; Severgnini, M.; Pietrelli, A.; Astori, C.; Fugazza, E.; Pascutto, C.; Boveri, E.; Passamonti, Francesco; De Bellis, G.; Vannucchi, A.; Cazzola, M.
ACUTE MYELOID LEUKEMIA (AML) HAVING EVOLVED FROM ESSENTIAL THROMBOCYTHEMIA (ET): DISTINCTIVE CHROMOSOME ABNORMALITIES IN PATIENTS TREATED WITH PIPOBROMAN OR HYDROXYUREA 1-gen-2002 Bernasconi, P.; Boni, M.; Cavigliano, P. M. .; Calatroni, S.; Brusamolino, E.; Passamonti, Francesco; Pistorio, A.; Giardini, I.; Rocca, B.; Caresana, M.; Lazzarino, M.; Brernasconi, C.
Adherence to ruxolitinib, an oral JAK1/2 inhibitor, in patients with myelofibrosis: interim analysis from an Italian, prospective cohort study (ROMEI) 1-gen-2022 Guglielmelli, P.; Palandri, F.; Selleri, C.; Cilloni, D.; Mendicino, F.; Mazza, P.; Pastore, D.; Palumbo, G. A.; Santoro, M.; Pavone, V.; Impera, S.; Morelli, M.; Coco, P.; Valsecchi, D.; Passamonti, F.; Breccia, M.
Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2 1-gen-2005 Kralovics, R; Teo, Ss; Buser, As; Brutsche, M; Tiedt, R; Tichelli, A; Passamonti, Francesco; Pietra, D; Cazzola, M; Skoda, Rc
Analysis of three screening methods for the detection of calreticulin gene mutations 1-gen-2020 Accetta, R.; Elli, L.; Libera, L.; Siracusa, C.; Cassavia, F.; Orsini, F.; Orlandi, L.; Passamonti, F.; Casalone, R.; Pallotti, F.
Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia 1-gen-2013 Squizzato, Alessandro; Romualdi, E.; Passamonti, Francesco; Middeldorp, S.
Aspirin in pregnant patients with essential thrombocythemia: a retrospective analysis of 129 pregnancies 1-gen-2009 Passamonti, Francesco; Rumi, E.; Randi, M. L.; Morra, E.; Cazzola, M.
Assessment of bone marrow involvement in non-Hodgkin's lymphomas: comparison between histology and flow cytometry. 1-gen-2010 Merli, M; Arcaini, L; Boveri, E; Rattotti, S; Picone, C; Passamonti, Francesco; Tenore, A; Sozzani, L; Lucioni, M; Varettoni, M; Rizzi, S; Morello, L; Ferretti, V; Pascutto, C; Paulli, Marco; Lazzarino, M.
Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: An analysis by the MPN QOL international working group 1-gen-2017 Geyer, H. L.; Kosiorek, H.; Dueck, A. C.; Scherber, R.; Slot, S.; Zweegman, S.; te Boekhorst, P. A. W.; Senyak, Z.; Schouten, H. C.; Sackmann, F.; Fuentes, A. K.; Hernández-Maraver, D.; Pahl, H. L.; Griesshammer, M.; Stegelmann, F.; Döhner, K.; Lehmann, T.; Bonatz, K.; Reiter, A.; Boyer, F.; Etienne, G.; Ianotto, J. -C.; Ranta, D.; Roy, L.; Cahn, J. -Y.; Harrison, C. N.; Radia, D.; Muxi, P.; Maldonado, N.; Besses, C.; Cervantes, F.; Johansson, P. L.; Barbui, T.; Barosi, G.; Vannucchi, A. M.; Paoli, C.; Passamonti, F.; Andreasson, B.; Ferrari, M. L.; Rambaldi, A.; Samuelsson, J.; Cannon, K.; Birgegard, G.; Xiao, Z.; Xu, Z.; Zhang, Y.; Sun, X.; Xu, J.; Kiladjian, J. -J.; Zhang, P.; Gale, R. P.; Mesa, R. A.
Balancing efficacy and safety of JAK inhibitors in myelofibrosis 1-gen-2014 Passamonti, Francesco
Bayesian models identify specific lymphoproliferative disorders associated with hepatitis C virus infection 1-gen-2009 Arcaini, L; Pascutto, C; Passamonti, Francesco; Bruno, R; Merli, M; Rizzi, S; Orlandi, E; Astori, C; Rattotti, S; Paulli, M; Lazzarino, M.
Biochemical markers of bone disease in asymptomatic early stage multiple myeloma. A study on their role in identifying high risk patients 1-gen-2001 Corso, A; Arcaini, L; Mangiacavalli, S; Astori, C; Orlandi, E; Lorenzi, A; Passamonti, Francesco; Klersy, C; Pascutto, C; Canevari Sciorati, A; Lazzarino, M.
Blast phase myeloproliferative neoplasm: Mayo-AGIMM study of 410 patients from two separate cohorts 1-gen-2018 Tefferi, Ayalew; Mudireddy, Mythri; Mannelli, Francesco; Begna, Kebede H.; Patnaik, Mrinal M.; Hanson, Curtis A.; Ketterling, Rhett P.; Gangat, Naseema; Yogarajah, Meera; de Stefano, Valerio; Passamonti, Francesco; Rosti, Vittorio; Finazzi, Maria Chiara; Rambaldi, Alessandro; Bosi, Alberto; Guglielmelli, Paola; Pardanani, Animesh; Vannucchi, Alessandro M.
Blast phase of essential thrombocythemia: A single center study. 1-gen-2009 Passamonti, Francesco; Rumi, E; Arcaini, L; Elena, C; Castagnola, C; Zappasodi, P; Bernasconi, P; Pietra, D; Pascutto, C; Cazzola, M; Lazzarino, M.
Blood p50 evaluation enhances diagnostic definition of isolated erythrocytosis. 1-gen-2009 Rumi, E; Passamonti, Francesco; Pagano, L; Ammirabile, M; Arcaini, L; Elena, C; Flagiello, A; Tedesco, R; Vercellati, C; Marcello, Ap; Pietra, D; Moratti, R; Cazzola, M; Lazzarino, M.
Blood tests may predict early primary myelofibrosis in patients presenting with essential thrombocythemia. 1-gen-2012 Carobbio, A; Finazzi, G; Thiele, J; Kvasnicka, Hm; Passamonti, Francesco; Rumi, E; Ruggeri, M; Rodeghiero, F; Luigia Randi, M; Bertozzi, I; Vannucchi, Am; Antonioli, E; Gisslinger, H; Buxhofer Ausch, V; Gangat, N; Rambaldi, A; Tefferi, A; Barbui, T.
Bone marrow histology in marginal zone B-cell lymphomas: correlation with clinical parameters and flow cytometry in 120 patients 1-gen-2009 Boveri, E; Arcaini, L; Merli, M; Passamonti, Francesco; Rizzi, S; Vanelli, L; Rumi, E; Rattotti, S; Lucioni, M; Picone, C; Castello, A; Pascutto, C; Lazzarino, M; Magrini, U; Paulli, M.
Bone marrow microvessel density in chronic myeloproliferative disorders: a study of 115 patients with clinicopathological and molecular correlations 1-gen-2008 Boveri, E; Passamonti, Francesco; Rumi, E; Pietra, D; Elena, C; Arcaini, L; Pascutto, C; Castello, A; Cazzola, M; Magrini, U; Lazzarino, M.
CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons 1-gen-2014 Tefferi, A.; Lasho, T. L.; Finke, C. M.; Knudson, R. A.; Ketterling, R.; Hanson, C. H.; Maffioli, M.; Caramazza, D.; Passamonti, Francesco; Pardanani, A.
Calreticulin mutation does not modify the IPSET score for predicting the risk of thrombosis among 1150 patients with essential thrombocythemia 1-gen-2014 Finazzi, G.; Carobbio, A.; Guglielmelli, P.; Cavalloni, C.; Salmoiraghi, S.; Vannucchi, A. M.; Cazzola, M.; Passamonti, Francesco; Rambaldi, A.; Barbui, T.